lenalidomide
Lenalidomide is a drug used to treat Multiple Myeloma, Chronic Lymphocytic Leukemia, Lymphoma, and other conditions. Lenalidomide is being actively studied in 277 studies and prior, has been studied in 263.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| M.D. Anderson Cancer Center | Mayo Clinic | Irene Ghobrial, MD |
| National Cancer Institute (NCI) | Washington University School of Medicine | Jacob Laubach |
| Celgene | Roswell Park Cancer Institute | Zhao Weili |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Active, not recruiting
- Multiple Myeloma
- Elotuzumab
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021S
A
Active, not recruiting
- Lymphoma
- Lenalidomide
- Philadelphia, PennsylvaniaJakub Svoboda
2021-10-04
Oct 4, 2021M
Active, not recruiting
- Mantle Cell Lymphoma
- Untreated
- Lenalidomide
- +2 more
- Basking Ridge, New Jersey
- +6 more
2022-02-17
Feb 17, 2022E
Not yet recruiting
- Multiple Myeloma
- Teclistamab
- Lenalidomide
- Melbourne, Australia
- +13 more
2022-02-07
Feb 7, 2022K
Recruiting
- Multiple Myeloma
- Lenalidomide
- Dexamethasone
- Busan, Western, Korea, Republic ofKosin University Gospel Hospital
2022-03-31
Mar 31, 2022D
Active, not recruiting
- Langerhans Cell Histiocytosis (LCH)
- +2 more
- Lenalidomide
- Boston, MassachusettsDana-Farber Cancer Institute
2022-02-11
Feb 11, 2022U
Completed
- Acute Myeloid Leukemia
- Lenalidomide
- Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill - Lineberger Compreh
2022-01-25
Jan 25, 2022U
Active, not recruiting
- Lymphoma
- Rituximab
- Lenalidomide
- Sacramento, CaliforniaUniversity of California Davis Cancer Center
2021-11-15
Nov 15, 2021N
Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas - 2019
Completed
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Lenalidomide
- XRT, 54-59.4 Gy
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2021-12-30
Dec 30, 2021U
Active, not recruiting
- Multiple Myeloma
- Lenalidomide
- +3 more
- Chicago, Illinois
- +2 more
2021-06-29
Jun 29, 2021F
Active, not recruiting
- Plasma Cell Myeloma
- Transplant-Related Carcinoma
- Ixazomib Citrate
- +2 more
- Seattle, WashingtonFred Hutchinson Cancer Research Center
2022-04-04
Apr 4, 2022B
Recruiting
- EBV Infection
- PD1 antibody
- lenalidomide
- Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
2022-01-04
Jan 4, 2022W
Active, not recruiting
- Multiple Myeloma
- Clarithromycin
- +2 more
- Aurora, Colorado
- +1 more
2022-02-01
Feb 1, 2022U
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Lenalidomide
- Sacramento, CaliforniaUniversity of California Davis
2022-03-08
Mar 8, 2022W
Completed
- Chronic Lymphocytic Leukemia
- thalidomide
- +2 more
- New York, New YorkWeill Cornell Medical College
2021-12-23
Dec 23, 2021M
Completed
- Alkylating Agent-Related Acute Myeloid Leukemia
- Secondary Acute Myeloid Leukemia
- Laboratory Biomarker Analysis
- Lenalidomide
- Houston, TexasM D Anderson Cancer Center
2021-12-17
Dec 17, 2021S
Recruiting
- Central Nervous System Lymphoma
- lenalidomide
- Seongnam-si, Please Select, Korea, Republic ofSeoul National University Bundang Hospital
2022-02-18
Feb 18, 2022T
Recruiting
- Relapsed/Refractory Peripheral T-cell Lymphoma
- Anti-PD-1 monoclonal antibody
- +2 more
- Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
2021-12-21
Dec 21, 2021U
Active, not recruiting
- Non Hodgkin's Lymphoma
- Rituximab
- Lenalidomide
- Sacramento, California
- +1 more
2021-11-15
Nov 15, 2021M
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- Plasma Cell Myeloma
- Ixazomib Citrate
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-03-08
Mar 8, 2022H
Completed
- Multiple Myeloma
- Lenalidomide
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-10-08
Oct 8, 2021B
Recruiting
- Relapsed/Refractory Marginal Zone Lymphoma
- Zanubrutinib
- +2 more
- Westbury, New YorkClinical Research Alliance, Inc.
2022-03-29
Mar 29, 2022H
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- High Dose Methylprednisolone (HDMP)
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2022-03-18
Mar 18, 2022S
Recruiting
- Multiple Myeloma
- GM-CSF vaccine
- +4 more
- Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022-01-06
Jan 6, 2022